 Participants in group LWI will receive a peri-articular injection of suspension 48 ml of 0.8 ropivacaine with 2 ml of 40mg methylprednisolone combined with intravenous non-opioid patient controlled analgesia.All participants will receive unified post-operative rehabilitation programme and the prophylaxis of infection and thrombo-embolism. 